Zeneca
Zeneca[edit | edit source]
Zeneca was a British multinational pharmaceutical company that was formed in 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries (ICI). Zeneca was headquartered in London, United Kingdom.
History[edit | edit source]
The formation of Zeneca was part of a strategic move by ICI to focus on its core chemicals business. Zeneca quickly established itself as a major player in the pharmaceutical industry, with a strong emphasis on research and development.
In 1999, Zeneca merged with the Swedish pharmaceutical company Astra AB to form AstraZeneca, one of the world's leading pharmaceutical companies. This merger was driven by the complementary strengths of the two companies, with Astra's expertise in gastrointestinal and cardiovascular drugs and Zeneca's strong oncology and respiratory portfolios.
Products[edit | edit source]
During its existence, Zeneca developed and marketed a range of pharmaceutical products. Some of the notable drugs included:
- Nolvadex (tamoxifen): A drug used in the treatment of breast cancer.
- Zoladex (goserelin): A medication used to treat prostate cancer and breast cancer.
- Seroquel (quetiapine): An antipsychotic used to treat schizophrenia and bipolar disorder.
Research and Development[edit | edit source]
Zeneca invested heavily in research and development, focusing on areas such as oncology, cardiovascular, and respiratory diseases. The company established several research facilities around the world, including in the United Kingdom and the United States.
Merger with Astra[edit | edit source]
The merger between Zeneca and Astra was announced in December 1998 and completed in April 1999. The new company, AstraZeneca, became one of the largest pharmaceutical companies in the world, with a strong presence in both Europe and the United States.
Legacy[edit | edit source]
Although Zeneca as a standalone company ceased to exist after the merger, its legacy continues through AstraZeneca. The merger allowed for the pooling of resources and expertise, leading to the development of new and innovative treatments for various diseases.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
